| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| BIOCRYST PHARMACEUTICALS INC | Chief Commercial Officer | Common Stock | 424K | $3.13M | $7.39 | Dec 19, 2024 | Direct |
| BIOCRYST PHARMACEUTICALS INC | Chief Commercial Officer | Emp. Stock Option (Right to Buy) | 261K | Dec 19, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| BCRX | BIOCRYST PHARMACEUTICALS INC | Dec 19, 2024 | 3 | -$18.2K | 4 | Dec 23, 2024 | Chief Commercial Officer |
| BCRX | BIOCRYST PHARMACEUTICALS INC | Dec 14, 2024 | 1 | -$62.1K | 4 | Dec 17, 2024 | Chief Commercial Officer |
| BCRX | BIOCRYST PHARMACEUTICALS INC | May 13, 2024 | 1 | $164K | 4 | May 15, 2024 | Chief Commercial Officer |
| BCRX | BIOCRYST PHARMACEUTICALS INC | Dec 19, 2023 | 1 | -$15K | 4 | Dec 20, 2023 | Chief Commercial Officer |
| BCRX | BIOCRYST PHARMACEUTICALS INC | Dec 14, 2023 | 3 | -$37.6K | 4 | Dec 18, 2023 | Chief Commercial Officer |
| BCRX | BIOCRYST PHARMACEUTICALS INC | Dec 19, 2022 | 2 | $0 | 4 | Dec 21, 2022 | Chief Commercial Officer |
| BCRX | BIOCRYST PHARMACEUTICALS INC | Dec 15, 2022 | 1 | -$66.5K | 4 | Dec 19, 2022 | Chief Commercial Officer |
| BCRX | BIOCRYST PHARMACEUTICALS INC | Dec 14, 2021 | 1 | $0 | 4/A | Jan 13, 2022 | Chief Commercial Officer |